| 32.89 Delayed Data As of Oct 19 |  +2.19 / +7.13%Today’s Change | 21.35 Today|||52-Week Range 60.30 | -28.66% Year-to-Date |
The investment seeks daily investment results- before fees and expenses- of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund- under normal circumstances- invests in swap agreements- futures contracts- short positions or other financial instruments that- in combination- provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
| 7 Leveraged/Inverse ETFs Off to a Strong Start in October Oct 09 / Zacks.com - Paid Partner Content |
| 1 month | +33.41% | 3 years | -57.25% | |
| 3 months | +50.98% | 5 years | -- | |
| 1 year | -29.77% | Since inception | -52.02% |
| Previous close | $30.70 |
| Open day’s range | 29.29 – 33.30 |
| Net asset value (NAV) | 33.02 (10/19/2018) |
| Daily volume | 1,967,820 |
| Average volume (3 months) | 1,428,062 |
| LABD | Category | |
|---|---|---|
| Performance 5-yr return | -- | -29.79% |
| Expense Gross exp ratio | 1.14% | 1.92% |
| Risk 5 year sharpe ratio | -- | -- |
| Net assets | $54.5M | $3.4M |
| Average market cap | -- | -- |
| Average P/E | -- | -- |
| Dividend / Share | -- | 0.35% |
| SH ProShares Short S&P500 |
| SDS ProShares UltraShort S&P500 |
| CHAD Direxion Daily CSI 300 China A Share Bea... |
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
| Holdings not available. |
